gvtcx

supplier

Octapharma Limited

M21AB combined from 2 published records

as a supplier

29 recorded awards from 12 buyers , between 1 Mar 2016 and 1 Jan 2025.

awards won
29
exclusive
34%
10 sole-winner awards
median award
£175,313
largest
£200,000

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) Norfolk and Norwich University Hospitals NHS Foundation Trust £71,550 1 Jan 2025
Octapharma Ltd - Octaplas LG Norfolk and Norwich University Hospitals NHS Foundation Trust £52,500 29 Apr 2023
Blood product required for the treatment of TTP patients University Hospitals of Leicester NHS Trust £97,500 1 Aug 2022
Octaplex Treatment Calderdale and Huddersfield NHS Foundati £100,000 30 Jun 2022
NHS NATIONAL FRAMEWORK AGREEMENT AGREEMENT FOR HUMAN ALBUMIN SOLUTION (HAS) shared HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST £222,864 25 Apr 2021
Supply of coagulopathy products BIRMINGHAM WOMENS AND CHILDRENS NHS FOUNDATION TRUST £200,000 23 Feb 2021
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared NHS England £334,400,000 2 Jun 2020
SD Plasma BIRMINGHAM CHILDREN'S HOSPITAL NHS FOUNDATION TRUST £200,000 5 Mar 2019
NHS Framework Agreement for the supply of products for the treatment of Bleeding Disorders shared NHS England £360,000,000 19 Jun 2018
Albumin and Anti-D Immunoglobulin shared Hull & East Yorkshire Hospitals Nhs Trust £225,000 29 Apr 2018
Solvent Detergent Treated FFP BIRMINGHAM CHILDRENS HOSPITAL £175,313 6 Mar 2018
National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders shared NHS England £302,000,000 24 Nov 2017
Octaplas BIRMINGHAM CHILDRENS HOSPITAL £175,313 24 Mar 2017
Octaplas LG BIRMINGHAM CHILDRENS HOSPITAL £149,813 1 Mar 2016
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
Human Derived Blood Products shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · 28 Aug 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England · 11 Jun 2024

every contract won by Octapharma Limited →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Octapharma Limited · M2 1AB 23
Octapharma Ltd GB-COH 02372699 · 6

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works